475 related articles for article (PubMed ID: 32198206)
1. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.
Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206
[TBL] [Abstract][Full Text] [Related]
2. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
Bohne LJ; Jansen HJ; Daniel I; Dorey TW; Moghtadaei M; Belke DD; Ezeani M; Rose RA
Heart Rhythm; 2021 Jan; 18(1):118-129. PubMed ID: 32911049
[TBL] [Abstract][Full Text] [Related]
3. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.
McCauley MD; Hong L; Sridhar A; Menon A; Perike S; Zhang M; da Silva IB; Yan J; Bonini MG; Ai X; Rehman J; Darbar D
Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008296. PubMed ID: 32654503
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12.
Pan Z; Ai T; Chang PC; Liu Y; Liu J; Maruyama M; Homsi M; Fishbein MC; Rubart M; Lin SF; Xiao D; Chen H; Chen PS; Shou W; Li BY
Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H371-H379. PubMed ID: 30499712
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.
Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D
J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
Jansen HJ; Mackasey M; Moghtadaei M; Belke DD; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
J Mol Cell Cardiol; 2018 Nov; 124():12-25. PubMed ID: 30273558
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of electrical remodeling of atrial myocytes and its influence on susceptibility to atrial fibrillation in diabetic rats.
Fu L; Rao F; Lian F; Yang H; Kuang S; Wu S; Deng C; Xue Y
Life Sci; 2019 Dec; 239():116903. PubMed ID: 31639397
[TBL] [Abstract][Full Text] [Related]
8. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation.
Poulet C; Wettwer E; Grunnet M; Jespersen T; Fabritz L; Matschke K; Knaut M; Ravens U
PLoS One; 2015; 10(6):e0131432. PubMed ID: 26121051
[TBL] [Abstract][Full Text] [Related]
9. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
[TBL] [Abstract][Full Text] [Related]
10. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
11. Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model.
Fu H; Li G; Liu C; Li J; Cheng L; Yang W; Tse G; Zhao J; Liu T
Oncotarget; 2016 Dec; 7(51):83850-83858. PubMed ID: 27863381
[TBL] [Abstract][Full Text] [Related]
12. Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice.
Sun YL; Li PH; Shi L; Su WZ; Li DS; Xue GL; Zhao Y; Li CZ; Li Y; Zhou Y; Li SX; Zhang Y; Lu YJ; Pan ZW
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1436-1443. PubMed ID: 30016000
[TBL] [Abstract][Full Text] [Related]
13. Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts.
Chu Y; Yang Q; Ren L; Yu S; Liu Z; Chen Y; Wei X; Huang S; Song L; Zhang P; Ma J; Wu L
J Cardiovasc Pharmacol; 2020 Oct; 76(4):437-444. PubMed ID: 32675747
[TBL] [Abstract][Full Text] [Related]
14. Atrial-ventricular differences in rabbit cardiac voltage-gated Na
Caves RE; Cheng H; Choisy SC; Gadeberg HC; Bryant SM; Hancox JC; James AF
Heart Rhythm; 2017 Nov; 14(11):1657-1664. PubMed ID: 28610990
[TBL] [Abstract][Full Text] [Related]
15. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
Baczko I; Liknes D; Yang W; Hamming KC; Searle G; Jaeger K; Husti Z; Juhasz V; Klausz G; Pap R; Saghy L; Varro A; Dolinsky V; Wang S; Rauniyar V; Hall D; Dyck JR; Light PE
Br J Pharmacol; 2014 Jan; 171(1):92-106. PubMed ID: 24102184
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice.
Zheng DL; Wu QR; Zeng P; Li SM; Cai YJ; Chen SZ; Luo XS; Kuang SJ; Rao F; Lai YY; Zhou MY; Wu FL; Yang H; Deng CY
Aging Cell; 2022 Dec; 21(12):e13734. PubMed ID: 36278684
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes.
Ko TH; Jeong D; Yu B; Song JE; Le QA; Woo SH; Choi JI
Pflugers Arch; 2023 Feb; 475(2):217-231. PubMed ID: 36274100
[TBL] [Abstract][Full Text] [Related]
19. Change in late sodium current of atrial myocytes in spontaneously hypertensive rats with allocryptopine treatment.
Dong Y; Huang Y; Wu HL; Ke J; Yin YL; Zhu C; Li B; Li J; Gao L; Xue Q; Zhang JC; Li Y
Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):79-86. PubMed ID: 30882133
[TBL] [Abstract][Full Text] [Related]
20. Exenatide reduces atrial fibrillation susceptibility by inhibiting hKv1.5 and hNav1.5 channels.
Zhou Q; Hao G; Xie W; Chen B; Lu W; Wang G; Zhong R; Chen J; Ye J; Shen J; Cao P
J Biol Chem; 2024 May; 300(5):107294. PubMed ID: 38636665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
